Related Experiment Videos

Urinary excretion of modified purines and nucleosides in immunodeficient children

Biochemical Medicine
|August 1, 1985
PubMed

Insights

Urinary purine and nucleoside levels were analyzed in children with severe combined immunodeficiency (SCID). Elevated levels of 1-methyladenosine and 1-methylinosine were observed in SCID patients, indicating potential biomarkers.

Area of Science:

  • Biochemistry
  • Immunology
  • Pediatrics

Background:

  • Severe combined immunodeficiency (SCID) is a group of rare genetic disorders characterized by profound defects in both the cellular and humoral immune systems.
  • Purines and nucleosides are fundamental components of nucleic acids and play crucial roles in various metabolic pathways.
  • Alterations in purine and nucleoside metabolism have been implicated in various diseases, including immune deficiencies.

Purpose of the Study:

  • To quantitatively determine urinary purines and nucleosides in children with SCID.
  • To identify potential biomarkers for SCID based on purine and nucleoside excretion patterns.
  • To compare these levels with those in healthy children.

Main Methods:

  • Utilized XAD-4 resin and ion-exchange chromatography for the analysis of urinary compounds.
  • Quantitatively determined specific methylated purines and nucleosides, including 1-methyladenosine, 1-methylinosine, and methylthioadenosine sulfoxide.
  • Included analyses of adenosine, cytidine, and deoxycytidine.

Main Results:

  • 1-Methyladenosine and 1-methylinosine were consistently elevated in the urine of children with SCID compared to normal controls.
  • Methylthioadenosine sulfoxide showed a marked increase in two SCID patients.
  • A germ-free child with SCID exhibited lower overall excretion levels of these compounds than normal children.

Conclusions:

  • Specific methylated purines and nucleosides, particularly 1-methyladenosine and 1-methylinosine, may serve as indicators for severe combined immunodeficiency.
  • Urinary purine and nucleoside profiles can provide insights into the metabolic disturbances associated with SCID.
  • Further research is warranted to explore the diagnostic and prognostic value of these biomarkers in SCID.

Related Concept Videos